Navigation Links
Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
Date:8/12/2009

BIRMINGHAM, Ala., Aug. 12 /PRNewswire/ -- Atherotech, Inc., developer of the VAP Cholesterol Test, has announced the addition of two new cardiometabolic tests as it continues to grow its cardiodiagnostic business.

The company has added the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early, sensitive marker for chronic kidney disease. The tests expand Atherotech's cardiovascular disease and metabolic panels that complement the company's advanced lipid profile, the VAP (Vertical Auto Profile) Test.

"We're seeing increased demand and experiencing strong growth in our business," said Atherotech President and CEO Mike Mullen, "and the marketplace is responding positively to our offering. Look for Atherotech to continue adding to the value of our core VAP lipid test by giving physicians and cardiology practices a single source for multiple cardiovascular disease and metabolic test panels."

Atherotech is privately held and doesn't disclose specific figures, but Mullen said that he expects revenues for his company to increase more than 20 percent in 2009 compared to last year, with profits increasing as well. Mullen believes the VAP lipid test is the centerpiece for this growth.

"We're providing valuable and clinically relevant information at a low cost, which leads to accurate diagnosis, targeted treatment and positive outcomes. This is a positive development for all stakeholders within our current health care environment, including managed care payers, patients, doctors and other health care providers," explained Mullen.

Cardiometabolic and genetic tests already available from Atherotech include C-Reactive Protein (hsCRP), apoE genotype, NT-proBNP, homocysteine, creatinine, creatine kinase (CK), HbA1c, TSH, ALT, AST, urea nitrogen (BUN), glucose, vitamin D and insulin. Cardiometabolic test panels can be ordered individually or bundled as part of a custom risk profile that also includes the VAP expanded cholesterol profile.

The VAP Cholesterol Test provides physician practices, researchers and health care providers with direct measurement of LDL, HDL and all relevant subclasses, and includes non-HDL, apoB, and emerging risk factors such as Lp(a), remnants and small dense LDL. The VAP Test is the only single cholesterol test that routinely reports apoAI, apoB and the apoB/apoAI ratio.

For more information call 877.901.8510 or visit www.thevaptest.com.

About Atherotech, Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.thevaptest.com.


'/>"/>
SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Atherotech to Exhibit The VAP Test at ADA 2008 Meeting in San Francisco
2. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
3. CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
4. Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference
5. Teens May Not Benefit from Pap Tests
6. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
7. Grupo Salinas, Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti-Litter and Recycling Contests
8. Most neuropsychological tests dont tell Alzheimers disease from vascular dementia
9. Buyer Beware! Know What Youre Getting When You Buy Online Genetic Tests
10. Larger hospital units have lower miscarriage rates after invasive pregnancy tests
11. Despite More Tests, Some Arent Getting Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , ... May 03, 2016 , ... Elizabeth Murray has ... parrots to join her with one on her shoulder and one on her arm. ... parking lot because of years of mitral valve prolapse. , The valves of the ...
(Date:5/3/2016)... ... ... Excessive panting in the car or cowering when new guests arrive are ... only manifests itself as trembling or ‘tail between the legs,’ but a pet ... about it,” says Dr. Jim Lowe, technical services veterinarian for Tomlyn pet health products ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... been selected by Tidelands Health, a three hospital system in South Carolina, to ... on the lookout for technology that enhances communication, drives workflow efficiencies and improves ...
(Date:5/3/2016)... ... 2016 , ... Boston Children’s Hospital today announced its new pediatric Simulation (SIM) ... or rare procedures in an environment that looks and feels real. , Located in ... inventors and “hackers” to develop and test new devices or software platforms and see ...
(Date:5/3/2016)... OH (PRWEB) , ... May 03, 2016 , ... Each ... a leading cause of death across the United States and account for one death ... and mental impairments or are permanently disabled. HCR ManorCare is launching a video series ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Click here for supplemental information regarding ... the nation,s largest independent specialty pharmacy, announced today ... acquire Valley Campus Pharmacy, Inc., doing business as ... pharmacy that provides individualized patient care, based in ... 2015, TNH generated approximately $400 million in revenue. ...
(Date:4/28/2016)... BURLINGAME, Calif. , April 28, 2016 /PRNewswire/ ... first-ever widely accessible breast and ovarian cancer risk ... cancer panel analyzing 30 genes that highly impact ... and women. Available today, the Color Test analyzes ... pancreatic, prostate, stomach, and uterine cancers. The Color ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 ... of online consumer insights on healthcare, announced today that ... in their report Cool Vendor in Life Sciences, ... , April 15, 2016.  The report focuses on life-science- ... to gain insight from patients and doctors, confirm medication ...
Breaking Medicine Technology: